What does Quest PharmaTech Inc. do?
Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.
What is Quest PharmaTech Inc.'s P/E and P/B ratio?
Quest PharmaTech Inc. has a P/E ratio of 0.7 and a P/B ratio of 0.13.
What is Quest PharmaTech Inc.'s debt-to-equity ratio?
Quest PharmaTech Inc. has a debt-to-equity ratio of 0.04.
What is Quest PharmaTech Inc.'s Positivity rank?
Quest PharmaTech Inc. is ranked #472 of 12,632 companies globally and #25 of 1,768 in Canada on PositoAI, with a Positivity Score of 24,859.
Does Quest PharmaTech Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Quest PharmaTech Inc..
Where can I read the latest news about Quest PharmaTech Inc.?
Recent headlines about Quest PharmaTech Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Quest PharmaTech Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Quest PharmaTech Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.